VIRMA and squamous cell lung carcinoma: Compared with the low-risk lung squamous cell carcinoma patients, the expressions of ALKBH5, METL3, HNRNPC, and KIAA1429 were significantly reduced in patients with high-risk lung squamous cell carcinoma.